Corrigendum to “Activation of Cerebral Recovery by Matrix Metalloproteinase-9 After Intracerebral Hemorrhage” [Neuroscience 230 (2013) 86–93](S0306452212011141)(10.1016/j.neuroscience.2012.11.008);Activation of cerebral recovery by matrix metalloproteinase-9 after intracerebral hemorrhage

Neuroscience

Volumn 230, Issue , 2013, Pages 86-93

  Lei, C ^a   Lin, S ^a   Zhang, C ^a   Tao, W ^a   Dong, W ^a   Hao, Z ^a   Liu, M ^a   Wu, B ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Intracerebral hemorrhage; Matrix metalloproteinase 9; Neurogenesis

Indexed keywords

BROXURIDINE; DOUBLECORTIN; GELATINASE B; NERVE GROWTH FACTOR; SMALL INTERFERING RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INJURY; CELL LABELING; CONTROLLED STUDY; CONVALESCENCE; ENZYME ACTIVATION; ENZYME REGULATION; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; WESTERN BLOTTING;

EID: 84871406757     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2021.11.040     Document Type: Erratum

References (40)

1. Aleksandrova N.P., Danilova G.A. Effect of intracerebroventricular injection of interleukin-1-beta on the ventilatory response to hyperoxic hypercapnia. Eur J Med Res 2010, 15(Suppl. 2):3-6.
2. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000, 2:737-744.
3. Barkho B.Z., Munoz A.E., Li X., Li L., Cunningham L.A., Zhao X. Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines. Stem Cells 2008, 26:3139-3149.
4. Bausch D., Pausch T., Krauss T., Hopt U.T., Fernandez-del-Castillo C., Warshaw A.L., Thayer S.P., Keck T. Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma. Angiogenesis 2011, 14:235-243.
5. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
6. Chopp M., Zhang Z.G., Jiang Q. Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke 2007, 38:827-831.
7. del Zoppo G.J. The neurovascular unit, matrix proteases, and innate Inflammation. Ann N Y Acad Sci 2010, 1207:46-49.
8. Ergul A., Alhusban A., Fagan S.C. Angiogenesis: a harmonized target for recovery after stroke. Stroke 2012, 3:2270-2274.
9. Fukuda S., Fini C.A., Mabuchi T., Koziol J.A., Eggleston L.L., del Zoppo G.J. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 2004, 35:998-1004.
10. Font M.A., Arboix A., Krupinski J. Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke. Curr Cardiol Rev 2010, 6:238-244.
11. Fu L.B., Wang X.B., Jiao S., Wu X., Yu L.C. Antinociceptive effects of intracerebroventricular injection of the galanin receptor 1 agonist M 617 in rats. Neurosci Lett 2011, 491:174-176.
12. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis the good, the bad, and the ugly. Circ Res 2002, 90:251-262.
13. Hu Q., Chen C., Yan J., Yang X., Shi X., Zhao J., Lei J., Yang L., Wang K., Chen L., Huang H., Han J., Zhang J.H., Zhou C. Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model. Exp Neurol 2009, 216:35-46.
14. Hao Q., Su H., Palmer D., Sun B., Gao P., Yang G.Y., Young W.L. Bone marrow-derived cells contribute to vascular endothelial growth factor-induced angiogenesis in the adult mouse brain by supplying matrix metalloproteinase-9. Stroke 2011, 42:453-458.
15. Jayanth P., Amith S.R., Gee K., Szewczuk M.R. Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for neurotrophin activation of Trk receptors and cellular signaling. Cell Signal 2010, 22:1193-1205.
16. Krum J.M., Mani N., Rosenstein J.M. Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury. Exp Neurol 2008, 212:108-117.
17. Kojima T., Hirota Y., Ema M., Takahashi S., Miyoshi I., Okano H., Sawamoto K. Subventricular zone-derived neural progenitor cells migrate along a blood vessel scaffold toward the post-stroke striatum. Stem Cells 2010, 28:545-554.
18. Lee S.R., Kim H.Y., Rogowska J., Zhao B.Q., Bhide P., Parent J.M., Lo E.H. Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J Neurosci 2006, 26:3491-3495.
19. Lee C.Z., Xue Z., Zhu Y., Yang G.Y., Young W.L. Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage. Stroke 2007, 38:2563-2568.
20. Montaner J., Alvarez-Sabín J., Molina C., Anglés A., Abilleira S., Arenillas J., González M.A., Monasterio J. Metalloproteinase expression after human cardioembolic stroke temporal profile and relation to neurological impairment. Stroke 2001, 32:1759-1766.
21. Nico B., Mangieri D., De Luca A., Corsi P., Benagiano V., Tamma R., Annese T., Longo V., Crivellato E., Ribatti D. Nerve growth factor and its receptors TrkA and p75 are upregulated in the brain of mdx dystrophic mouse. Neuroscience 2004, 161:1057-1066.
22. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., Costa R.M., Silva A.J., Kaczmarek L., Huntley G.W. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci 2006, 26:1923-1934.
23. Okauchi M., Hua Y., Keep R.F., Morgenstern L.B., Xi G. Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats. Stroke 2009, 40:1858-1863.
24. Park K.P., Rosell A., Foerch C., Xing C., Kim W.J., Lee S., Opdenakker G., Furie K.L., Lo E.H. Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rat. Stroke 2009, 40:2836-2842.
25. Pratheeshkumar P., Kuttan G. Vernolide-A inhibits radiation-induced hypoxia-mediated tumor angiogenesis by regulating HIF-1î±, MMP-2, MMP-9, and VEGF. J Environ Pathol Toxicol Oncol 2011, 30:139-151.
26. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998, 29:1020-1030.
27. Rosell A., Lo E.H. Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol 2008, 8:82-89.
28. Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999, 19:5731-5740.
29. Shubayev V.I., Myers R.R. Matrix metalloproteinase-9 promotes nerve growth factor-induced neurite elongation but not new sprout formation in vitro. J Neurosci Res 2004, 77:229-239.
30. Shen J., Xie L., Mao X., Zhou Y., Zhan R., Greenberg D.A., Jin K. Neurogenesis after primary intracerebral hemorrhage in adult human brain. J Cereb Blood Flow Metab 2008, 28:1460-1468.
31. Shimotake J., Derugin N., Wendland M., Vexler Z.S., Ferriero D.M. Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke. Stroke 2010, 41:343-349.
32. Tang T., Liu X.J., Zhang Z.Q., Zhou H.J., Luo J.K., Huang J.F., Yang Q.D., Li X.Q. Cerebral angiogenesis after collagenase-induced intracerebral hemorrhage in rats. Brain Res 2007, 17(1175):134-142.
33. Tetè S., Zara S., Zizzari V.L., De Carlo A., Vinci R., Cataldi A., Gherlone E. Immunohistochemical analysis of matrix metalloproteinase-9, vascular endothelial growth factor, bone sialoprotein and i-nitric oxide synthase in calvaria vs. iliac crest bone grafts. Clin Oral Implants Res 2011, 23:1254-1260.
34. Vu T.H., Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000, 14:2123-2133.
35. Wang L., Zhang Z.G., Zhang R.L., Gregg S.R., Hozeska-Solgot A., LeTourneau Y., Wang Y., Chopp M. Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J Neurosci 2006, 26:5996-6003.
36. Xue M.Z., Wee Yong V. Matrix metalloproteinases in intracerebral hemorrhage. Neurol Res 2008, 30:775-782.
37. Yagi K., Kitazato K.T., Uno M., Tada Y., Kinouchi T., Shimada K., Nagahiro S. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator. Stroke 2009, 40:626-631.
38. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N., Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000, 106:829-838.
39. Zhao B.Q., Wang S., Kim H.Y., Storrie H., Rosen B.R., Mooney D.J., Wang X., Lo E.H. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 2006, 12:441-445.
40. Zhao B.Q., Tejima E., Lo E.H. Neurovascular proteases in brain injury. Hemorrhage and remodeling after stroke. Stroke 2007, 38:748-752.